GROUP AGREEMENTGroup Agreement • March 9th, 2023 • Apeiron Investment Group Ltd. • Pharmaceutical preparations
WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Sensei Biotherapeutics, Inc., a Delaware corporation (the “Company”);
APEIRON INVESTMENT GROUP LTD. Beatrice, at 66 & 67 Amery Street, SLM1707 Sliema, MaltaApeiron Investment Group Ltd. • March 9th, 2023 • Pharmaceutical preparations
This letter sets forth our mutual agreement with respect to compensation to be paid to you for your agreement to be named and serve as a nominee of Apeiron Investment Group Ltd. (“Apeiron”) for election as a director of Sensei Biotherapeutics, Inc. (the “Company”) at the Company’s 2023 annual meeting of stockholders including any other meeting of stockholders held in lieu thereof, and any adjournments, postponements, reschedulings or continuations thereof (the “Annual Meeting”).
